Overview

Flumazenil

CAS

78755-81-4

Status

Commercial

Flumazenil is an imidazobenzodiazepine derivative and a benzodiazepine antagonist. Competitive inhibition of GABAA makes it possible to use flumazenil as an antidote to drugs that act like benzodiazepines (e.g., Z-drugs). The rapid onset (two minutes) is useful in cases of overdosing, but also in relieving anesthesia. The effect lasts only about two hours, the long duration of action of benzodiazepines must be considered here. It can also be used in primary hypersomnia.

Description

Formula

C15H14FN3O3

Molecular weight

303.29 g/mol

Molecular size

small

Controlled Substance

yes

Precursor

no

Indications

All other therapeutic products

Your Contact

Marius Hang

Marius Hang

International Division
Director API Export

Midas Pharma GmbH
Rheinstr. 49
55218 Ingelheim
Germany
  • Disclaimer

    The information contained herein is the proprietary information of Midas Pharma GmbH and its affiliates. This information is provided to you solely for your evaluation, to determine your interest in a potential business relationship with Midas Pharma GmbH and/or its affiliates. Midas Pharma GmbH excludes any express or implied representations, guarantees or warranties of whatsoever nature, including but not limited to the warranties for the completeness or accuracy of the information provided herein.

    No information provided herein – including any reference to any product or service – constitutes an offer for sale, or shall be construed as representing an offer for sale. In particular, nothing herein should be construed as a promotion or advertisement for any product, or for the use of any product, that infringes valid patents and/or is not authorized by the laws and regulations of your country of residence.

Complementary Services

Share this page